Esophagus Cancer Recruiting Phase 2 / 3 Trials for Tegafur (DB09256)

IndicationStatusPhase
DBCOND0032126 (Esophagus Cancer)Recruiting2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02979691Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esophagogastric Cancer - 3JECROG P-01Treatment